| 2024/04/19 18:34:26 | |
|---|---|
| Price | |
| 26.93 EUR | |
| Difference | 1.39% (0.37) |
General attributes
| ISIN | DE0005785604 |
| Symbol | FRE |
| Exchange | Frankfurt |
| Currency | EUR |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 15,151 EUR |
| Benchmark | GERMANY DAX |
Market data
| Bid (Bid size) | 26.81 EUR (470) |
| Ask (Ask size) | 26.94 EUR (468) |
| Open | 26.36 EUR |
| High | 26.93 EUR |
| Low | 25.96 EUR |
| Close (prev. day) | 26.56 EUR |
| VWAP | 26.46078 EUR |
| Volume (pcs) | 1,930 |
| Trading volume | 51,069.30 |
| Number of trades | 7 |
| Last size | 150 |
Futures and Options
| Related Futures | 53 |
| Related Options | - |
PDF Downloads
| Company report: FRESENIUS SE & CO. KGAA |  |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Recent research
| Date | Headline | Download | |
| 2022/05/04 |
|
Global Equity Ratings |
|
| 2022/04/27 |
|
Global Equity Ratings |
|
| 2022/04/14 |
|
Global Equity Ratings |
|
| 2022/03/29 |
|
Global Equity Ratings |
|
| 2022/03/10 |
|
Global Equity Ratings |
|
| 2024/04/19 18:34:26 | |
|---|---|
| Price | |
| 26.93 EUR | |
| Difference | 1.39% (0.37) |
General attributes
| ISIN | DE0005785604 |
| Symbol | FRE |
| Exchange | Frankfurt |
| Currency | EUR |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 15,151 EUR |
| Benchmark | GERMANY DAX |
Market data
| Bid (Bid size) | 26.81 EUR (470) |
| Ask (Ask size) | 26.94 EUR (468) |
| Open | 26.36 EUR |
| High | 26.93 EUR |
| Low | 25.96 EUR |
| Close (prev. day) | 26.56 EUR |
| VWAP | 26.46078 EUR |
| Volume (pcs) | 1,930 |
| Trading volume | 51,069.30 |
| Number of trades | 7 |
| Last size | 150 |
Performance and Risk
| 6m | 1Y | 3Y | |
| Perf (%) | +7.84% | +3.03% | -31.00% |
| Perf (abs.) | +1.93 | +0.78 | -11.93 |
| Beta | 0.70 | 0.81 | 0.74 |
| Volatility | 23.18 | 26.56 | 27.57 |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Price data
| Ø price 5 days | Ø volume 5 days (pcs.) | 26.07 EUR (2,414) |
| Ø price 30 days | Ø volume 30 days (pcs.) | 25.28 EUR (2,370) |
| Ø price 100 days | Ø volume 100 days (pcs.) | 26.62 EUR (3,008) |
| Ø price 250 days | Ø volume 250 days (pcs.) | 26.93 EUR (2,747) |
| YTD High | date | 29.16 EUR (2024/01/03) |
| YTD Low | date | 24.39 EUR (2024/03/26) |
| 52 Weeks High | date | 31.15 EUR (2023/09/21) |
| 52 Weeks Low | date | 24.06 EUR (2023/10/11) |
All listings for FRESENIUS SE & CO. KGAA
| Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
| Xetra | 2024/04/19 | 17:35 | 26.90 EUR | 36.77 | 2,879 |
| Vienna Stock Exchange | 2024/04/19 | 17:32 | 26.86 EUR | 0.00 | 4 |
| Tradegate | 2024/04/19 | 19:46 | 26.95 EUR | 1.42 | 224 |
| Stuttgart | 2024/04/19 | 20:35 | 26.81 EUR | 0.21 | 157 |
| SIX Swiss Exchange | 2023/02/17 | 17:35 | 29.00 EUR | 0.00 | 1 |
| SIX Swiss Exchange | 2020/04/01 | 05:55 | 53.06 CHF | 0.00 | 1 |
| Munich | 2024/04/19 | 08:00 | 26.40 EUR | 0.00 | 1 |
| London Stock Exchange European Trade Reporting | 2024/04/19 | 17:30 | 26.795 EUR | 0.00 | 1 |
| Hanover | 2024/04/19 | 13:15 | 26.50 EUR | 0.00 | 3 |
| Hamburg | 2024/04/19 | 20:16 | 26.94 EUR | 0.02 | 6 |
| Frankfurt | 2024/04/19 | 18:34 | 26.93 EUR | 0.05 | 7 |
| FINRA other OTC Issues | 2024/04/19 | 16:40 | 26.65 USD | 0.01 | 2 |
| Euronext Milan MTF Trading After Hours | 2024/02/23 | 18:00 | 26.45 EUR | 0.01 | 1 |
| Euronext Milan MTF Global Equity Market | 2024/04/19 | 17:44 | 26.88 EUR | 0.00 | 2 |
| Duesseldorf | 2024/04/19 | 19:31 | 26.77 EUR | 0.00 | 5 |
| Berlin | 2024/04/19 | 20:34 | 26.87 EUR | 0.00 | 15 |
Company Logo
Contact Details
| FRESENIUS SE & CO. KGAA |
| - - |
| Else-Kröner-Strasse 1 - 61352 Bad Homburg |
| Telefon: +49-6172-608-0 |
| Fax: +49-6172-608-2628 |
| E-mail: pr-fre@fresenius.com |
PDF Downloads
| Company report: FRESENIUS SE & CO. KGAA | |
Company Profile
Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care. It operates through the following segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios and Fresenius Vamed. The Fresenius Medical Care segment caters to individuals with renal diseases. The Fresenius Kabi segment specializes in lifesaving medicines and technologies. The Fresenius Helios offers expertise in inpatient and outpatient care as well as in telemedicine. The Fresenius Vamed segment manages projects and services for hospitals and other healthcare facilities. The company was founded by Eduard Fresenius on October 1, 1912 and is headquartered in Bad Homburg, Germany. |
Members of Management Board
| Michael Sen | Chairman of Managing Board |
| Michael Moser | Member of Executive Committee |
| Helen Ping Giza | Member of Executive Committee |
| Pierluigi Antonelli | Member of Executive Committee |
| Robert Möller | Member of Executive Committee |
| Sara Lisa Hennicken | Member of Executive Committee |
Board of directors
| Wolfgang Kirsch | Chairman of Supervisory Board |
| Christoph Zindel | Member of Supervisory Board |
| Iris Löw-Friedrich | Member of Supervisory Board |
| Michael Albrecht | Member of Supervisory Board |
| Bernd Behlert | Member of Supervisory Board |
| Frauke Lehmann | Member of Supervisory Board |
| Grit Genster | Member of Supervisory Board |
| Holger Michel | Member of Supervisory Board |
| Konrad Kölbl | Member of Supervisory Board |
| Michael Diekmann | Member of Supervisory Board |
| Oscar Romero de Paco | Member of Supervisory Board |
| Susanne Zeidler | Member of Supervisory Board |